|
|
|
|
Alcohol prescriptions on the riseThe number of prescriptions given out to treat alcohol dependency has increased, figures for England show.Source: BBC News | Health | World Edition | 27 May 2010 | 1:43 am Uncertainty over Medicare pay sets doctors on edge (AP)
Source: Yahoo! News: Health News | 27 May 2010 | 1:39 am Mexico to ban junk food from schools to fight fat (AP)AP - Mexico is looking to battle the bulging waistlines of its children by banning the sale of junk food in its schools, including many of the traditional treats generations of kids have grown up with.Source: Yahoo! News: Health News | 27 May 2010 | 1:23 am Sanofi prostate cancer drug shows 28 percent survivalPARIS (Reuters) - Sanofi-Aventis' cabazitaxel candidate prostate cancer drug combined with prednisone reduced the risk of death by 28 percent compared with another treatment, the outcome ofSource: RSS feed - channel BNewsHealth | 27 May 2010 | 1:09 am Gaultier to quit HermesFrench couturier Jean-Paul Gaultier is stepping down as artistic director of the luxury ready-to-wear brand Hermes after seven years to concentrate on his own projects, the group announced...Source: RSS feed - channel BNewsHealth | 27 May 2010 | 1:05 am Asia in search of its own J.K. RowlingPublishers and authors are looking for that little bit of magic that could see Asia produce the next J.K. Rowling. The British writer's best-selling series about boy wizard Harry Potter...Source: RSS feed - channel BNewsHealth | 27 May 2010 | 12:48 am Mexico to ban junk food from schools to fight fatMexico is looking to battle the bulging waistlines of its children by banning the sale of junk food in its schools, including many of the traditional treats generations of kids have grown...Source: RSS feed - channel BNewsHealth | 27 May 2010 | 12:35 am Trigemina, Inc. Reports Preliminary Results For Phase IIa Clinical Trial In Chronic Daily HeadacheTrigemina, Inc. (TI), a Mountain View based privately-held biopharmaceutical company, reports positive results from a time-based interim analysis of its Phase IIa clinical trial in Chronic Daily Headache (CDH). The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from CDH. CDH represents approximately 3% of the US population for which there currently is no effective treatment...
Source: Health News from Medical News Today | 27 May 2010 | 12:00 am Detoxifying the HomeA New York “building biology” consultant can evaluate apartments for environmental hazards, checking everything from scented candles to shower heads. Source: NYT > Health | 26 May 2010 | 11:45 pm Study: Tanning triples melanoma riskPeople who regularly use tanning beds may double or even triple their risk of developing melanoma, the deadliest form of skin cancer, according to a new study.Source: CNN.com - Health | 26 May 2010 | 11:11 pm New Breed of Specialist Steps In for Family DoctorHospitalists have increasingly taken over the care of the hospitalized patient from entry through discharge.Source: NYT > Health | 26 May 2010 | 11:10 pm AHF To Obama: Solve US AIDS Drug Crisis NowAs many states across the nation face budget and funding shortfalls that are crippling their lifesaving AIDS Drug Assistance Programs (ADAPs), AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is urging President Barack Obama to redirect a portion of unspent stimulus funds in the Health and Human Services Department in order to address the growing ADAP crisis...
Source: Health News from Medical News Today | 26 May 2010 | 11:00 pm Study Questions Financing for High-Risk Health PoolsA research group says the new health care law will not provide enough money for up to seven million Americans with pre-existing conditions, without changes in coverage.Source: NYT > Health | 26 May 2010 | 10:40 pm Study Finds Condom Use Is IncreasingWomen in the United States are found to generally follow a pattern of turning first to condoms, then the pill, and later, sterilization.Source: NYT > Health | 26 May 2010 | 10:37 pm UPDATE 1-Khazanah's $835mln Parkway offer pits it against Fortis* Khazanah offers S$1.18 bln to up stake in Parkway to 51.5%Source: RSS feed - channel BNewsHealth | 26 May 2010 | 10:37 pm Skin Deep: Gold Face Cream: A Costly Leap of FaithDoctors and cosmetics companies disagree about whether gold, which is being used in masks and creams, can help the skin.Source: NYT > Health | 26 May 2010 | 10:35 pm TABLE-SCORPION OFFSHORE 3-month resultsMay 27 (Reuters) - 3 months to March 31 2010: Scorpion Offshore Ltd (Millions of USD unless otherwise stated)Source: RSS feed - channel BNewsHealth | 26 May 2010 | 10:30 pm In E. Coli Fight, Some Strains Are Largely IgnoredAs the food industry and government regulators have focused on one virulent strain of the bacteria E. Coli, six others are emerging as a serious threat to food safety.Source: NYT > Health | 26 May 2010 | 10:22 pm GTx Announces Top Line Results Of Phase III Trial Evaluating Toremifene 20 Mg For The Prevention Of Prostate Cancer In Men With High Grade PINGTx, Inc. (Nasdaq: GTXI) announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate. Incidence of prostate cancer was lower in men receiving toremifene 20 mg compared to placebo but not statistically significantly different (p=0.385). A 10.2% relative risk reduction at three years was observed...
Source: Health News from Medical News Today | 26 May 2010 | 10:00 pm Malaysia's Khazanah makes $835 mln for Parkway's stakeSINGAPORE, May 27 (Reuters) - Malaysia's sovereign fund Khazanah offered to raise its stake in Singapore healthcare firm Parkway Holdings to 51.5 percent in a S$1.18 billion ($835 million) deal.Source: RSS feed - channel BNewsHealth | 26 May 2010 | 9:48 pm FDA Warns of Fracture Risk With Popular Heartburn Drugs (HealthDay)HealthDay - TUESDAY, May 25 (HealthDay News) -- Blockbuster heartburn medications such as Prevacid, Prilosec and Nexium will now carry a warning on their labels linking the drugs to a heightened risk for fractures, the U.S. Food and Drug Administration announced late Tuesday.Source: Yahoo! News: Health News | 26 May 2010 | 9:48 pm Prenatal Exposure to Chemicals Linked to Breast Cancer Risk (HealthDay)HealthDay - WEDNESDAY, May 26 (HealthDay News) -- The children of women who are exposed to certain industrial chemicals while pregnant are at an increased risk for developing breast cancer as adults, a new animal study suggests.Source: Yahoo! News: Health News | 26 May 2010 | 9:48 pm 'The Pill' Is Birth Control Favorite in U.S. (HealthDay)HealthDay - WEDNESDAY, May 26 (HealthDay News) -- Give it up for The Pill: 50 years after it was invented, the oral contraceptive remains the leading method of birth control in the United States, a new report says, just edging out female sterilization.Source: Yahoo! News: Health News | 26 May 2010 | 9:48 pm Brain Cells May Serve as Clot-Busters (HealthDay)HealthDay - WEDNESDAY, May 26 (HealthDay News) -- Researchers report that they've discovered how tiny blood vessels remove blood clots from the brain in mice -- a finding that could help scientists gain a better understanding of how to treat people who suffer from Alzheimer's disease and stroke.Source: Yahoo! News: Health News | 26 May 2010 | 9:48 pm Shark Cartilage Not Beneficial in Advanced Lung Cancer (HealthDay)HealthDay - WEDNESDAY, May 26 (HealthDay News) -- A drug derived from shark cartilage failed to improve survival in patients with advanced lung cancer, researchers report.Source: Yahoo! News: Health News | 26 May 2010 | 9:48 pm Rare Cases of Liver Damage Tied to Weight-Loss Drug (HealthDay)HealthDay - WEDNESDAY, May 26 (HealthDay News) -- Responding to reports of rare but sometimes severe cases of liver damage, U.S. health officials on Wednesday announced revised labels for a widely used weight-loss drug.Source: Yahoo! News: Health News | 26 May 2010 | 9:48 pm India's Suzlon to consider rights issue on SaturdayMUMBAI, May 27 (Reuters) - Indian wind turbine maker Suzlon Energy said on Thursday its board would consider on Saturday a rights share issue. (Reporting by Ami Shah)Source: RSS feed - channel BNewsHealth | 26 May 2010 | 9:48 pm India's Ambanis to reach gas deal in 2 weeks-paperNEW DELHI, May 27 (Reuters) - Indian energy major Reliance Industries and Reliance Natural Resources Ltd will reach a gas supply agreement in the next two weeks, taking forward a patch-up between the...Source: RSS feed - channel BNewsHealth | 26 May 2010 | 9:33 pm Questions for Drug Makers on Manufacturing DefectsCongress will try to learn why bits of metal and other impurities were found in drugs made by two companies.Source: NYT > Health | 26 May 2010 | 9:31 pm Some Ignored Heart Tests at Harlem Hospital Showed ProblemsThe results of 4,000 echocardiograms had never been seen by doctors at Harlem Hospital Center because of a practice of allowing technicians to read them first.Source: NYT > Health | 26 May 2010 | 9:10 pm NovoStent Announces 6-Month Results Of SAMBA Femoropopliteal TrialNovoStent Corporation, a privately held medical device company, announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBATM Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility. Professor Dr...
Source: Health News from Medical News Today | 26 May 2010 | 9:00 pm UPDATE 3-Sanofi to invest in Japan generic drug maker -Nikkei* Sanofi to use deal to enter Japan generic market - NikkeiSource: RSS feed - channel BNewsHealth | 26 May 2010 | 8:54 pm Report: Trans fat limits lead to healthier foods (AP)
Source: Yahoo! News: Health News | 26 May 2010 | 8:53 pm Targeted Patient Enrollment Reached In Phase IIb Clinical Trial For Epicept™ NP-1 In Chemotherapy-Induced Peripheral NeuropathyEpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that the targeted enrollment in a Phase IIb trial for EpiCept™ NP-1 in chemotherapy-induced peripheral neuropathy (CPN) has been attained. The trial is being conducted by National Cancer Institute (NCI)-funded Community Clinical Oncology Program. EpiCept™ NP-1 is a patented topical cream formulation of two FDA- approved drugs, 4% amitriptyline and 2% ketamine, and is intended to provide long-term relief from the pain of peripheral neuropathies...
Source: Health News from Medical News Today | 26 May 2010 | 8:00 pm Boston Scientific Begins Platinum Plus Trial For Promus(R) Element™ Stent SystemBoston Scientific Corporation (NYSE: BSX) today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS® Element™ Everolimus-Eluting Coronary Stent System to the XIENCE PRIME™ Everolimus-Eluting Coronary Stent System. The PROMUS Element Stent, which received CE Mark in October 2009, is Boston Scientific's third-generation drug-eluting stent technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system...
Source: Health News from Medical News Today | 26 May 2010 | 7:00 pm CREST Trial Published, but Debate Continues on Stenting vs Surgery for Symptomatic Carotid DiseaseThe CREST trial, first reported in February, showed similar net outcomes for carotid stenting vs endarterectomy, but editorialists say they are sticking with surgery for symptomatic disease.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 6:56 pm Philips Launches Award Program To Improve Health And Well-being Of People Living In CitiesRoyal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the launch of the Philips Livable Cities Award, an initiative designed to generate practical, achievable ideas for improving the health and well-being of people living in cities. Individuals, community or non-governmental groups and businesses are eligible to participate in the Award program that comprises a total prize fund amounting to 125,000 Euros...
Source: Health News from Medical News Today | 26 May 2010 | 6:00 pm Arthritis 'on rise in US women'One of the most common forms of arthritis is on the rise in US women but falling among men, according to a study.Source: BBC News | Health | World Edition | 26 May 2010 | 5:53 pm Hospitals warned on vagina swabsMidwives and other staff who help deliver babies are warned not to leave swabs inside the vaginas of new mothers.Source: BBC News | Health | World Edition | 26 May 2010 | 5:40 pm Siemens Healthcare Showcases Powerhouse Duo Of Imaging IT Solutions At SIIM 2010Siemens Healthcare, a leading provider of innovative imaging IT solutions, will demonstrate the next generation of advanced visualization and agile PACS technologies when it exhibits syngo®.via1 and syngo®.plaza at the Society for Imaging Informatics in Medicine (SIIM) 2010 Annual Meeting in Minneapolis, Minn., June 3-6 (booth #411). These latest additions to Siemens' syngo portfolio represent new benchmarks in delivering cutting-edge case preparation, image reading and archiving functionality to the clinical routine...
Source: Health News from Medical News Today | 26 May 2010 | 5:00 pm FDA Clears OCT System for Interventional CardiologyFDA clears the first optical coherence tomography system for vascular imaging.Heartwire Source: Medscape Medical News Headlines | 26 May 2010 | 4:49 pm Cutting Intake of Sugar-Sweetened Drinks Lowers BP in Observational StudyThe links between blood pressure and intake of "regular" soft drinks and other beverages with added sugars were significant over 18 months, with or without consideration of changes in body weight.Heartwire Source: Medscape Medical News Headlines | 26 May 2010 | 4:49 pm Drug cocktails cut couples' HIV transmission risk (Reuters)Reuters - In a study that supports the widespread use of drugs to help control the AIDS pandemic, researchers said on Wednesday that HIV patients who took the drugs were far less likely to infect their partners.Source: Yahoo! News: Health News | 26 May 2010 | 4:37 pm Prime-time television tackles autismIn a scene from NBC's "Parenthood," two parents are attempting to get their 8-year-old son ready for school. The child insists on wearing a pirate costume to class, again. His father asks him to take it off so he won't get teased. His mother says it's OK, mainly so she can get him out the door on time.Source: CNN.com - Health | 26 May 2010 | 4:20 pm New Data Analyses Of CONCERTA(R) Efficacy On ADHD In The ClassroomTurning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD),[1] according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges...
Source: Health News from Medical News Today | 26 May 2010 | 4:00 pm Virtual Reality Exposure Enhances Treatment of PTSDIn a small study, 9 of 10 subjects with combat-related PTSD who underwent virtual reality exposure greatly improved.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 3:07 pm Kantar Health's Research On Burdens On Caregivers For Adults With Epilepsy Wins Best Poster In New Investigator Category At 2010 ISPOR MeetingKantar Health, a leading healthcare-focused global consultancy and marketing insights company, has won "Best Poster" in the new investigator category at the 2010 ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Annual International Meeting. The poster, "Health Status, Resource Utilization, and Work Productivity for Caregivers of Adults with Epilepsy: A Propensity Score Analysis of National Survey Data," was developed in conjunction with a major pharmaceutical company and co-written by Marco DiBonaventura, Ph.D...
Source: Health News from Medical News Today | 26 May 2010 | 3:00 pm Everyday plastic, toxic fearsIn fear of toxic waste, chemical exposure, companies and hospitals are halting use of polyvinyl chloride, found in everything from electric cords to medical tubing.Source: CNN.com - Health | 26 May 2010 | 2:48 pm Pediatricians Urge Warning Labels on Foods That Can ChokeThe American Academy of Pediatrics says that food can pose lethal hazards to young children and should be subject to as much scrutiny as toys.Source: NYT > Health | 26 May 2010 | 2:41 pm U.S. to revisit gay blood donation banSince 1983, gay men have not been allowed to donate blood in the United States. This month, a federal advisory panel will reconsider the issue.Source: CNN.com - Health | 26 May 2010 | 2:29 pm Brain Shrinkage in Anorexia Is ReversibleAnorexics with the eating disorder in which they lose excessive weight also have shrinking brains. But regaining the weight can also reverse the reduction in brain volume.Source: Livescience.com - Health | 26 May 2010 | 2:12 pm Radiation Does Not Improve Survival in Elderly Early-Stage Breast Cancer PatientsLumpectomy plus tamoxifen might be sufficient for older women with estrogen-receptor-positive early-stage disease. Long-term follow-up shows no survival benefit with adjuvant radiotherapy.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 1:54 pm 5 Things to Know About HerpesSteering clear of genital herpes is possible with the right precautions.Source: NYT > Health | 26 May 2010 | 12:33 pm FDA Adds Risk for Severe Liver Injury to Orlistat LabelThe agency notes, however, that it has not yet established a cause-and-effect relationship between orlistat use and liver damage.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 12:23 pm Lenalinomide Maintenance Halves Multiple Myeloma RelapseInterim results from a phase 3 study show that lenalinomide maintenance therapy for multiple myeloma halves the relapse rate.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 11:45 am RESOLUTE: Zotarolimus-Eluting "DES-Strong" Matches Xience at One YearA next-generation zotarolimus-coated Driver stent, with a rejiggered polymer to better control drug eluting, has proved itself seemingly identical to the Xience, although a higher rate of stent thrombosis in the newer device has raised some eyebrows.Heartwire Source: Medscape Medical News Headlines | 26 May 2010 | 11:45 am Tai Chi May Improve Some ADHD SymptomsA new study suggests tai chi chuan may help some ADHD symptoms, but practice needs to be maintained for treatment effect.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 11:24 am High Caffeine Intake During Pregnancy Linked to Reduced Fetal LengthA cohort study shows that caffeine intake of 6 or more units per day during pregnancy is associated with impaired fetal length growth.Medscape Medical News Source: Medscape Medical News Headlines | 26 May 2010 | 11:03 am FDA: Some heartburn drugs carry fracture riskSome heartburn medications could increase the risk of hip, wrist and spine fractures in high doses or with long-term use, the Food and Drug Administration warned.Source: CNN.com - Health | 26 May 2010 | 7:02 am Warning that World Cup will see hangovers hit a highMore than half a million Britons go to work with a hangover each day and the figure is set to soar with the World Cup, experts say.Source: BBC News | Health | World Edition | 26 May 2010 | 5:48 am Births to older mothers 'trebled'The number of births to older mothers in England and Wales almost trebled in 20 years and is continuing to rise, figures show.Source: BBC News | Health | World Edition | 26 May 2010 | 5:11 am
|
